Attralus Therapeutics
Joseph Suttner is an experienced clinical operations executive with a robust career spanning over a decade in leadership roles within the pharmaceutical and biotechnology sectors. Currently serving as Vice President of Clinical Operations at Attralus since February 2022, Joseph has previously held similar positions at PellePharm, Dermira, Inc., and Aimmune Therapeutics. Joseph began professional tenure as Director of Clinical Operations at Ipsen and later transitioned to Director of Clinical Development at Peplin Ltd. Joseph holds an MBA in Business Administration, Management and Operations from the University of Liverpool and a Bachelor's degree from California State University, Long Beach.
Attralus Therapeutics
Attralus is a clinical stage biopharmaceutical company focused on creating transformative medicines to improve the lives of patients with systemic amyloidosis.